Strata Critical Medical Inc (SRTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 50,180 | -7,236 | -3,493 | -27,307 | -17,514 |
| Depreciation Amortization | 5,177 | 3,473 | 1,697 | 5,962 | 4,432 |
| Income taxes - deferred | 558 | 4 | -17 | -255 | -150 |
| Accounts receivable | -8,551 | -6,777 | -520 | -998 | -3,611 |
| Other Working Capital | 2,779 | -5,208 | 795 | -3,021 | -3,239 |
| Other Operating Activity | -90,750 | 12,434 | 1,292 | 23,100 | 19,315 |
| Operating Cash Flow | $-40,607 | $-3,310 | $-246 | $-2,519 | $-767 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -76,095 | -96,403 | -84,197 | -143,255 | -142,766 |
| PPE Investments | -7,747 | -4,849 | -2,614 | -30,862 | -26,286 |
| Net Acquisitions | -65,174 | N/A | N/A | -2,230 | -2,230 |
| Purchase Of Investment | 203,000 | 151,300 | 107,750 | 177,450 | 167,950 |
| Purchase Sale Intangibles | -1,258 | -961 | -532 | -2,119 | -1,660 |
| Other Investing Activity | -2,499 | -961 | -532 | -2,119 | -1,660 |
| Investing Cash Flow | $51,485 | $49,087 | $20,407 | $-1,016 | $-4,992 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 139 | 74 | 60 | 168 | 124 |
| Common Stock Repurchased | N/A | 0 | N/A | -244 | -244 |
| Other Financing Activity | -7,309 | -5,457 | -4,306 | -5,683 | -1,765 |
| Financing Cash Flow | $-7,170 | $-5,383 | $-4,246 | $-5,759 | $-1,885 |
| Exchange Rate Effect | -339 | 277 | 126 | -80 | 29 |
| Beginning Cash Position | 19,647 | 19,647 | 19,647 | 29,021 | 29,021 |
| End Cash Position | 23,016 | 60,318 | 35,688 | 19,647 | 21,406 |
| Net Cash Flow | $3,369 | $40,671 | $16,041 | $-9,374 | $-7,615 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,607 | -3,310 | -246 | -2,519 | -767 |
| Capital Expenditure | N/A | -4,918 | -2,619 | -30,875 | N/A |
| Free Cash Flow | -40,607 | -8,228 | -2,865 | -33,394 | -767 |